X
Record #18951

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

Original paper date
Apr 3, 2017
Institution
Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA · Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA · Pasarow Mass Spectrometry Laboratory, University of California Los Angeles, Los Angeles, CA, 90095, USA · Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles, Los Angeles, CA, 90095, USA · Office of Laboratory Animal Care, University of California Berkeley, Berkeley, CA, 94720, USA · UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, CA, 90095, USA · Molecular Biology Institute, University of California Los Angeles, Los Angeles, CA, 90095, USA · Department of Biological Chemistry, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, 90095, USA · The VA Greater Los Angeles Healthcare System, Los Angeles, CA, 90073, USA
Open access
No
Article type
Research Article
Broad categories
(BLS) Biology - Cancer(BLS) Biology - Cellular(BLS) Toxicology
Citation lifecycle

How this paper is being cited

Pre-retraction
2
Same day
0
Post-retraction
8
% post-retraction
80.0%
~1.5 citations/yr before retraction · ~1.0 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse